FIELD: medicine; pharmaceuticals.
SUBSTANCE: use of the compound of formula I for preparing a medicinal agent for: 1) neuroprotection, 2) preventing or treating neurodegenerative diseases; disclosed are methods of 1) protecting neurons by administering said compound of a pharmaceutical composition and 2) preventing or treating neurodegenerative diseases by administering said pharmaceutical composition.
EFFECT: pharmaceutical composition of compound of formula I due to antioxidant action and stabilization of mitochondrial membrane in neurons prevents apoptosis and on model of Parkinson's disease treats diseases associated with apoptosis or with neurodegeneration.
8 cl, 24 dwg, 1 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
| SUBSTITUTED AZOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES, AND METHODS OF TREATING PARKINSON'S DISEASE WITH USING THESE DERIVATIVES | 2010 |
|
RU2578596C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DEGENERATIVE NEUROLOGICAL DISORDERS WHICH COMPRISES, AS AN ACTIVE INGREDIENT, A MIXED ROOT EXTRACT OF THE TREE PEONY ROOT, THE ROOT OF DAHURIC ANGELICA AND THE ROOT OF THOROWAX OR ITS FRACTION | 2015 |
|
RU2668135C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2540470C9 |
| SOLID DISPERSIONS OF INSOLUBLE DRUGS AND METHODS OF THEIR PREPARATION | 2013 |
|
RU2646491C2 |
| RASAGILINE COMPOSITIONS OF PROLONGED RELEASE AND USE THEREOF | 2011 |
|
RU2607595C2 |
| RASAGILINE COMPOSITIONS WITH PROLONGED RELEASE AND USE THEREOF | 2011 |
|
RU2734632C2 |
| PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
| USE OF BENZOATE FOR TREATMENT OF DISORDERS OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2780450C2 |
| ALPHA-SYNUCLEIN MODULATORS | 2018 |
|
RU2797677C2 |
